Belpointe Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,568
Closed -$65.6K – 914
2023
Q1
$65.6K Sell
1,568
-990
-39% -$41.7K ﹤0.01% 1557
2022
Q4
$111K Buy
+2,558
New +$109K 0.01% 1184

Other funds holding BME

Belpointe Asset Management's BME Position: Q2 2023 in Review

Belpointe Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 1,568 shares — an estimated $65.6K sold.

Belpointe Asset Management first reported a position in BME in Q4 2022 and held it in 2 quarters. The position peaked at $111K in Q4 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.

  • Belpointe Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 1,568 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $65.6K.
  • Belpointe Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's BlackRock Health Sciences Trust position peaked at $111K in Q4 2022.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.